On September 1, 2023, the International Co-Innovation Center for Advanced Medical Technology (iCCAMT) embarked on a groundbreaking mission to Switzerland, accompanied by a high-level delegation representing the Nanjing government and local enterprises. Together, they orchestrated the much-anticipated "Nanjing-Swiss (Zurich) Investment Promotion Session," a pivotal event aimed at fostering innovation collaboration between China and Switzerland, expanding into the European market, and charting new paths of development.

Keynote Speech: Dr. Matthias Hölling, Director of the Technopark Alliance

The Technopark Alliance proudly showcased five trailblazing Swiss enterprises during the session: Securecell AG, STIMIT AG, Medical Templates AG, Belvista (Suisse) Sarl, and MYNERVA AG. These cutting-edge companies engaged in productive discussions with the Nanjing delegation, exploring the vast potential for collaboration and project opportunities in Nanjing. This collaborative effort has laid a robust foundation for future ventures.

The climax of the event was marked by the signing of a "Switzerland-China Health Technology Strategic Collaboration Memorandum of Understanding" between Technopark Zurich and the Nanjing Municipal Investment Promotion Center. This landmark agreement solidifies their commitment to enhancing collaboration in the healthcare industry, academia, and research sectors.

The Signing of the " Switzerland – China Health Technology Strategic Cooperation Memorandum of Understanding" between Technopark Zurich and the Nanjing Municipal Investment Promotion Center